Skip to content
Global sound
Drug Discovery AI Talk

Drug Discovery AI Talk

by Dr. Jake Chen

Latest episode
#80. The Agent Swarm

About this podcast

Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews

Episodes

The newest 20 of 79 episodes

  • #80. The Agent Swarm · 19 min · Season 2 Episode 80Three fresh stories, one question: what happens when AI stops being a chatbot and starts doing the work of a lab? A swarm of AI agents reads millions of brain cells in minutes…
  • #79. Can AI Drug the Undruggable? · 22 min · Season 2 Episode 79Three fresh stories, one question: what happens when AI stops needing a protein's 3D shape and starts working with biology as it actually behaves? A virtual cell trained on…
  • #78. From Too Few to Too Many · 22 min · Season 2 Episode 78AI can now generate millions of molecules, thousands of drug targets, and entire scientific manuscripts in hours — but our capacity to validate any of it hasn't kept pace. This…
  • #77. Virtual Biology's Reality Check · 26 min · Season 2 Episode 77Biohub's Virtual Biology Initiative just expanded to $1.8 billion — backed by the DOE, NIH, Google DeepMind, Isomorphic Labs, and Meta — to build the data foundations for…
  • #76. AI's Phase III Moment · 22 minOn September 10, 2026, Insilico Medicine dosed the first patient in the Phase III GENESIS-IPF-3 trial of rentosertib (ISM001-055) for idiopathic pulmonary fibrosis - the first…
  • #75. The AI Patent Landscape 2026 · 21 min · Season 2 Episode 32In this episode, we examine how AI-native biotechnology companies are reshaping drug discovery through the lens of their intellectual-property portfolios. The evidence suggests…
  • #74. Is Drug Discovery AI Safe? · 21 min · Season 2 Episode 31In this podcast, we study how integrating agentic AI into autonomous wet labs promises rapid therapeutic innovation, while connecting autonomous models directly to physical lab…
  • #73. The Triumph of Daraxonrasib · 19 min · Season 2 Episode 30For decades, KRAS stood as oncology’s archetypal “undruggable” target—a powerful cancer driver with no obvious pocket for conventional medicines to grasp. This episode explores…
  • #72. 2026 Emerging Trends · 24 min · Season 2 Episode 29In this podcast, we show a pivotal shift in 2026 for AI drug discovery toward integrated, AI-native R&D systems that move beyond simple algorithmic tasks to form closed-loop…
  • #71. Magic Wands · 24 min · Season 2 Episode 28In this episode, we critically examine whether AI drug discovery is solving the hardest problems in medicine—or simply making the easier ones faster. At the center of the…
  • #70. Beyond AlphaFold · 23 min · Season 2 Episode 27In this episode, we venture beyond protein structure prediction into the messy, stochastic reality of modeling the virtual cell. We examine why biology still lacks an…
  • #69. CollaboFest · 23 min · Season 2 Episode 26What if we could turn a spark of biological insight into a real-world, life-saving treatment? That is the core mission of CollaboFest, an innovative initiative designed to break…
  • #68. Molecular Glues in Therapy · 22 min · Season 2 Episode 25In this episode, we explore the rapid evolution of molecular glues, a breakthrough in targeted protein degradation that stabilizes protein interactions to treat previously…
  • #67. Does Size Matter? · 21 min · Season 2 Episode 24In this episode, we examine whether increasing the size and depth of neural networks truly enhances molecular property prediction compared to traditional machine learning. A…
  • #66. Quantitative Systems Pharmacology · 26 min · Season 2 Episode 23In this episode, we explore the evolving role of Quantitative Systems Pharmacology (QSP) in drug development, particularly as a mechanistic alternative to traditional animal…
  • #65. Orbiting around Big Pharma · 20 min · Season 2 Episode 22In this episode, we explore Lilly TuneLab as a major signal of where AI drug discovery may be heading: toward powerful platform ecosystems that combine proprietary pharmaceutical…
  • #64. Foundation Models · 21 min · Season 2 Episode 21In this episode, we explore the surge of foundation models (FMs) within pharmaceutical research, noting that over 200 such models were published by early 2025. Unlike traditional…
  • #63. The Era of NAMs · 21 min · Season 2 Episode 20This podcast explores the transformative shift toward New Approach Methodologies (NAMs), which utilize human-relevant experimental and computational systems to modernize drug…
  • #62. Predicting Toxicity · 19 min · Season 2 Episode 19In this episode, we investigate the significant evolution of AI-driven toxicity prediction, detailing how the field has shifted from simple statistical models to sophisticated…
  • #61. AI Era Evidence Flywheel · 22 min · Season 2 Episode 18In this episode, Dr. Jake Chen provides his narrative review and advocates for a fundamental shift in pharmaceutical research, moving away from inefficient trial-and-error toward…

More like this

All News podcasts →

Live, last hour: 10,513 songs on 5,407 stations in 145 countries

Discover the world through radio

More ways to discover (9)

Heard something good? Save it, or open it straight away in Spotify.

Boxmode RádióContinue listening